Up to and including 31 March 2021, the MHRA had received 79 UK reports of blood clotting cases alongside low levels of platelets following the use of the Covid-19 vaccine AstraZeneca:
44 of the 79 cases were of CVST with thrombocytopenia.
35 of the 79 cases were of thrombosis in other major veins with thrombocytopenia.
79 cases occurred in 51 women and 28 men, aged from 18 to 79 years. It should be noted that more women have been vaccinated with Covid-19 Vaccine AstraZeneca than men.
Sadly, 19 people have died out of the 79 cases – 13 females and 6 males. 11 out of the 19 people who died were under the age of 50, 3 of whom were under 30. 14 of these 19 cases were of CVST with thrombocytopenia and 5 were of thrombosis with thrombocytopenia.
All 79 cases occurred after a first dose of the vaccine.